The Government of India has officially announced a significant change in API Import Duty India 2025, effective from August. This move is a part of the larger policy to promote domestic manufacturing of Active Pharmaceutical Ingredients (APIs) under the Atmanirbhar Bharat initiative. The updated duty structure introduces increased import tariffs on over 40 high-demand APIs, … Read more
The Government of India has released a major update in June 2025 regarding its ambitious Bulk Drug Park Scheme, a cornerstone of India’s pharmaceutical self-reliance strategy. Under this scheme, the government has sanctioned fresh subsidy allocations to three key states to accelerate the production of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and intermediates. … Read more
India continues to solidify its position as the pharmacy of the world with remarkable progress in Pharma Export India 2025. The country has seen a sharp rise in exports of pharmaceutical formulations, bulk drugs (APIs), and biotechnology products, crossing new trade milestones in global markets. According to the Ministry of Commerce and Industry, India’s pharmaceutical … Read more
The government of India has released the Jan Aushadhi Medicine List 2025, bringing updated prices and expanded availability of essential generic medicines across the country. Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), the Ministry of Chemicals and Fertilizers continues its commitment to provide affordable healthcare by offering quality medicines at substantially reduced rates through … Read more